Ankita Mitra

Ankita Mitra

University of Massachusetts Amherst

H-index: 2

North America-United States

About Ankita Mitra

Ankita Mitra, With an exceptional h-index of 2 and a recent h-index of 2 (since 2020), a distinguished researcher at University of Massachusetts Amherst, specializes in the field of immunology, T cell, Cancer Immmunotherapy, tumor immunology, immunotheraapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion

Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcomes in solid tumors

A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance

LKB1 isoform expression modulates T cell plasticity downstream of PKCθ and IL-6

An immunosuppressive ectoenzyme-expressing T cell population is associated with non-responsiveness to immune checkpoint blockade in metastatic melanoma patients

1040 A population of ectoenzyme expressing T-cells with an immunosuppressive phenotype are associated with checkpoint immunotherapy resistance in metastatic melanoma patients

Correction to “Targeting CD4+ Cells with Anti-CD4 Conjugated Mertansine Loaded Nanogels”

Abstract PO030: A Novel T-cell Population Expressing the Ectoenzymes CD38 and CD39 is Associated with Melanoma Patient Non-Response to Immunotherapy

Ankita Mitra Information

University

Position

___

Citations(all)

32

Citations(since 2020)

32

Cited By

5

hIndex(all)

2

hIndex(since 2020)

2

i10Index(all)

2

i10Index(since 2020)

2

Email

University Profile Page

Google Scholar

Ankita Mitra Skills & Research Interests

immunology

T cell

Cancer Immmunotherapy

tumor immunology

immunotheraapy

Top articles of Ankita Mitra

Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion

Biology

2024/4/28

Ankita Mitra
Ankita Mitra

H-Index: 1

Anoop Kumar
Anoop Kumar

H-Index: 16

Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcomes in solid tumors

2024/2

Ankita Mitra
Ankita Mitra

H-Index: 1

Anirban Ganguly
Anirban Ganguly

H-Index: 1

A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance

Clinical Cancer Research

2023/10/13

LKB1 isoform expression modulates T cell plasticity downstream of PKCθ and IL-6

Molecular Immunology

2023/5/1

An immunosuppressive ectoenzyme-expressing T cell population is associated with non-responsiveness to immune checkpoint blockade in metastatic melanoma patients

Cancer Research

2023/4/4

Ankita Mitra
Ankita Mitra

H-Index: 1

Brian Thompson
Brian Thompson

H-Index: 1

1040 A population of ectoenzyme expressing T-cells with an immunosuppressive phenotype are associated with checkpoint immunotherapy resistance in metastatic melanoma patients

2022/11/1

Correction to “Targeting CD4+ Cells with Anti-CD4 Conjugated Mertansine Loaded Nanogels”

Biomacromolecules

2021/2/12

Abstract PO030: A Novel T-cell Population Expressing the Ectoenzymes CD38 and CD39 is Associated with Melanoma Patient Non-Response to Immunotherapy

Cancer Immunology Research

2021/2/1

Ankita Mitra
Ankita Mitra

H-Index: 1

Itai Yanai
Itai Yanai

H-Index: 30

Targeting CD4+ Cells with Anti-CD4 Conjugated Mertansine-Loaded Nanogels

Biomacromolecules

2020/5/8

CD28 signaling drives notch ligand expression on CD4 T cells

Frontiers in Immunology

2020/5/7

REGULATION OF NOTCH LIGAND EXPRESSION ON CD4 T CELLS

2020

Ankita Mitra
Ankita Mitra

H-Index: 1

See List of Professors in Ankita Mitra University(University of Massachusetts Amherst)

Co-Authors

academic-engine